Published in Cancer Lett on October 08, 2014
Oncogenic transformation of Drosophila somatic cells induces a functional piRNA pathway. Genes Dev (2016) 1.47
Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology. Sci Rep (2015) 0.97
Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas. J Exp Clin Cancer Res (2015) 0.92
Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing. BMC Med Genomics (2015) 0.89
Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer. Oncotarget (2016) 0.86
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. Curr Genomics (2015) 0.81
HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer. Oral Oncol (2016) 0.81
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients. Onco Targets Ther (2016) 0.79
Detection of stably expressed piRNAs in human blood. Int J Clin Exp Med (2015) 0.78
Germ cell and tumor associated piRNAs in the medaka and Xiphophorus melanoma models. BMC Genomics (2016) 0.78
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Oncotarget (2016) 0.75
piR-651 and its function in 95-D lung cancer cells. Biomed Rep (2016) 0.75
MicroRNAs and PIWI-interacting RNAs in oncology. Oncol Lett (2016) 0.75
Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer. PLoS One (2016) 0.75
Putative RNA-Directed Adaptive Mutations in Cancer Evolution. Transcription (2016) 0.75
piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1. Cancer Sci (2017) 0.75
Application of combined computed tomography arteriography, venography, and urography in laparoscopic partial nephrectomy with segmental artery clamping. Urology (2014) 1.98
Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep (2015) 1.06
A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget (2015) 0.97
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells. DNA Cell Biol (2015) 0.90
A functional variant in miR-143 promoter contributes to prostate cancer risk. Arch Toxicol (2014) 0.90
MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis. PLoS One (2013) 0.85
Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies. Int Urol Nephrol (2016) 0.79
Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population. PLoS One (2012) 0.79
A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site. Int J Cancer (2016) 0.78
Reply: To PMID 25306472. Urology (2014) 0.75
Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma. Oncotarget (2016) 0.75
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. Eur Urol (2017) 0.75
Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features. Cancer Genet (2014) 0.75
The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Oncotarget (2017) 0.75
The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma. Oncotarget (2017) 0.75
Super-Selective Artery Embolization before Laparoscopic Partial Nephrectomy in Treating Renal Angiomyolipoma. Urol Int (2017) 0.75
Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3. Cancer Res (2016) 0.75